Status:
COMPLETED
Study of a Pandemic Influenza Vaccine in Elderly Participants
Lead Sponsor:
Seqirus
Conditions:
Influenza
Eligibility:
All Genders
65+ years
Phase:
PHASE2
Brief Summary
The World Health Organisation has warned that an influenza pandemic is inevitable. The avian influenza H5N1 virus strain is one of the leading candidates to cause the next influenza pandemic. The elde...
Eligibility Criteria
Inclusion
- Healthy male and female participants
Exclusion
- History of clinically significant medical conditions
- History of Guillain-Barre syndrome or active neurological disease
- Resident of nursing home or long-term care facility
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
End Date :
June 1 2007
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00376402
Start Date
October 1 2006
End Date
June 1 2007
Last Update
July 19 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CMAX, a division of IDT Australia
Adelaide, South Australia, Australia, 5000
2
Princess Margaret Hospital for Children
Perth, Western Australia, Australia, 6840